These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20576958)

  • 21. Peripheral nerve monitoring in children undergoing neuromuscular blockade after single-stage laryngotracheoplasty.
    Malis DJ; Burton DM
    Laryngoscope; 1996 Jul; 106(7):919-21. PubMed ID: 8667995
    [No Abstract]   [Full Text] [Related]  

  • 22. [Neuromuscular blockade monitoring. Part 1].
    Ariño-Irujo JJ; Calbet-Mañueco A; De la Calle-Elguezabal PA; Velasco-Barrio JM; López-Timoneda F; Ortiz-Gómez JR; Fabregat-López J; Palacio-Abizanda FJ; Fornet-Ruiz I; Pérez-Cajaraville J
    Rev Esp Anestesiol Reanim; 2010 Mar; 57(3):153-60. PubMed ID: 20422848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical limitations of acetylcholinesterase antagonists.
    Caldwell JE
    J Crit Care; 2009 Mar; 24(1):21-8. PubMed ID: 19272535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Beware of the residual curarization!].
    Baillard C
    Ann Fr Anesth Reanim; 2005 Oct; 24(10):1245-6. PubMed ID: 16099133
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
    White PF; Tufanogullari B; Sacan O; Pavlin EG; Viegas OJ; Minkowitz HS; Hudson ME
    Anesth Analg; 2009 Mar; 108(3):846-51. PubMed ID: 19224792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Residual neuromuscular blockade and upper airway muscles.
    Duvaldestin P
    Anesthesiology; 2010 Jan; 112(1):246; author reply 246-7. PubMed ID: 20032709
    [No Abstract]   [Full Text] [Related]  

  • 27. Method of intraoperative monitoring of neuromuscular function and residual blockade in the recovery room.
    Jones KA; Lennon RL; Hosking MP
    Minn Med; 1992 Jul; 75(7):23-6. PubMed ID: 1357537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuromuscular block: views from the Western pacific.
    Futter M; Gin T
    Anesth Analg; 2010 Jul; 111(1):11-2. PubMed ID: 20576961
    [No Abstract]   [Full Text] [Related]  

  • 29. Residual neuromuscular block: rediscovering the obvious.
    Brull SJ; Naguib M; Miller RD
    Anesth Analg; 2008 Jul; 107(1):11-4. PubMed ID: 18635461
    [No Abstract]   [Full Text] [Related]  

  • 30. Selective relaxant binding agents for reversal of neuromuscular blockade.
    Bom A; Epemolu O; Hope F; Rutherford S; Thomson K
    Curr Opin Pharmacol; 2007 Jun; 7(3):298-302. PubMed ID: 17368102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sugammadex: a novel agent for the reversal of neuromuscular blockade.
    Nicholson WT; Sprung J; Jankowski CJ
    Pharmacotherapy; 2007 Aug; 27(8):1181-8. PubMed ID: 17655516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antagonism of non-depolarising neuromuscular block: current practice.
    Kopman AF; Eikermann M
    Anaesthesia; 2009 Mar; 64 Suppl 1():22-30. PubMed ID: 19222428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring neuromuscular blockade in the intensive care unit: the peripheral nerve stimulator.
    Rowlee SC
    Heart Lung; 1999; 28(5):352-62; quiz 363-4. PubMed ID: 10486453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extremely prolonged neuromuscular blockade after rocuronium: a case report.
    Morales Martín AC; Vaquero Roncero LM; Muriel Villoria C
    Acta Anaesthesiol Scand; 2009 Aug; 53(7):957-9. PubMed ID: 19397500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nondepolarizing Neuromuscular Blocking Agents, Reversal, and Risk of Postoperative Pneumonia.
    Bulka CM; Terekhov MA; Martin BJ; Dmochowski RR; Hayes RM; Ehrenfeld JM
    Anesthesiology; 2016 Oct; 125(4):647-55. PubMed ID: 27496656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Neostigmine-resistant curarization".
    Baraka A
    Middle East J Anaesthesiol; 2013 Jun; 22(2):131-4. PubMed ID: 24180159
    [No Abstract]   [Full Text] [Related]  

  • 37. Acquired neuromuscular disorders in the intensive care unit.
    Deem S; Lee CM; Curtis JR
    Am J Respir Crit Care Med; 2003 Oct; 168(7):735-9. PubMed ID: 14522811
    [No Abstract]   [Full Text] [Related]  

  • 38. Neostigmine product for NMBA reversal approved by FDA.
    Thompson CA
    Am J Health Syst Pharm; 2013 Jul; 70(14):1184. PubMed ID: 23820450
    [No Abstract]   [Full Text] [Related]  

  • 39. Delayed reversal of a potentiated rocuronium neuromuscular block.
    Dubois PE
    Eur J Anaesthesiol; 2009 Apr; 26(4):350-2. PubMed ID: 19401670
    [No Abstract]   [Full Text] [Related]  

  • 40. [Neuromuscular blockade monitoring. Part 2].
    Ortiz-Gómez JR; Fabregat-López J; Palacio-Abizanda FJ; Fornet-Ruiz I; Pérez-Cajaraville J; Ariño-Irujo JJ; Calbet-Mañueco A; De la Calle-Elguezabal PA; Velasco-Barrio JM; López-Timoneda F
    Rev Esp Anestesiol Reanim; 2010 Mar; 57(3):161-72. PubMed ID: 20422849
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.